27 November 2015 SATVI announces the appointment of Chief Operations Officer
The South African Tuberculosis Vaccine Initiative has appointed Dr Masooda Kaskar as the Chief Operations Officer as from January 2016. She has held several senior leadership positions within the Pharmaceutical Industry. At Novartis she was instrumental in developing and implementing Transformational Growth Plans that resulted in establishing Novartis’s Leadership position within the industry. Her experience spans Strategy, Operations, Marketing as well as Managed Health Care. As Head of the Respiratory Division she was instrumental in driving improvements in the area of Cystic Fibrosis management as well as changing the landscape of Severe Asthma by launching the first anti-IgE therapy for the treatment of Severe Allergic Asthma in South Africa. Masooda holds an MBCHB degree from the University of Cape Town, as well as a MBA from UCT Graduate School of Business.